PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsFour gene mutations lower heart attack risk

BioNews

Four gene mutations lower heart attack risk

Published 20 June 2014 posted in News and appears in BioNews 759

Author

Dr Charlotte Warren-Gash

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Four rare gene mutations may protect against heart attacks by lowering levels of a type of fat called triglycerides, according to research in the New England Journal of Medicine.

Four rare gene
mutations may protect against heart attacks by lowering levels of a type of fat
called triglycerides, according to research in the New England Journal of
Medicine
.

Triglyceride
levels in the blood were 39 percent lower in carriers of the mutations, which
affect the APOC3 gene, than in non-carriers.

Researchers analysed
blood from nearly 4,000 participants from the USA's National Heart, Lung and
Blood Institute's Exome Sequencing Project
. Around one in every 150 people carried
an APOC3 mutation and were found to have a 40 percent reduced risk of heart
attacks.

'Based
on our findings, we predict that lowering triglycerides specifically through
inhibition of APOC3 would have a beneficial effect by lowering disease risk',
said Professor Alex Reiner, senior co-author of the study from the University of
Washington.

Heart
problems are known to be linked to levels of a type of cholesterol, low density
lipoproteins (LDL). But the role of other blood lipids such as high density
lipoproteins (HDL) and triglycerides in heart disease is less clear.

Dr Sekar
Kathiresan
, director of preventive cardiology at Massachusetts General
Hospital, senior author of the study, said: 'HDL and
triglycerides are both correlated with heart attack, and have an inverse
relationship with one another — the lower the HDL the higher the triglycerides'.

'It
has long been presumed that low HDL is the causal factor in heart disease and
triglycerides are just along for the ride. But our genetic data indicate that
the true causal factor may not be HDL after all, but triglycerides',
he added.

Current heart
disease prevention therapies such as statins target raised levels of LDL, the
so-called 'bad cholesterol'. However some patients go on to have further heart
attacks even after being treated with drugs to lower LDL. This study helps to
explain the origins of this residual risk.

'Although statins
remain a powerful arrow in the quiver, the notion of residual risk of coronary
heart disease continues to be a significant clinical problem',
commented Dr Kathiresan. 'Our study really reinvigorates the idea of
lowering triglycerides and specifically by blocking APOC3 as a viable
therapeutic strategy for addressing residual risk'.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 September 2016 • 2 minutes read

Rare mutation may protect against heart disease

by Rachel Reeves

A rare genetic mutation reduces the risk of having a heart attack by one-third, a study has found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 December 2014 • 2 minutes read

Gene found to double risk of heart attacks.

by Dr Molly Godfrey

Scientists have identified a set of rare gene mutations that may increase the risk of early heart attacks...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 November 2014 • 3 minutes read

Gene mutation carriers get equivalent of lifetime's anti-cholesterol treatment

by Dr Lanay Griessner

An inactive copy of a gene associated with cholesterol levels can reduce the risk of a heart attack, according to a study...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
16 June 2014 • 2 minutes read

Injectable gene therapy 'could prevent heart attacks'

by Dr Kimberley Bryon-Dodd

Genes linked to cholesterol levels have been successfully edited in mice who received a single injection, thereby reducing their risk of heart disease, according to a study...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 May 2014 • 2 minutes read

Genetic test for heart condition rolled out across UK

by Dr Nicoletta Charolidi

A genetic test that can predict a preventable form of heart disease is being introduced into several NHS hospitals...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
12 May 2014 • 2 minutes read

Can stem cells 'mend broken hearts'? Studies raise both hope and doubt

by Dr Greg Ball

Two major reviews of clinical trials using stem cells to treat advanced heart disease have found a positive effect of the stem cell treatment, but caution against overstating this effect until more trials are carried out...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
2 May 2014 • 3 minutes read

Human stem cells repair heart damage in monkeys

by Dr Rachael Panizzo

Heart cells derived from human embryonic stem cells are capable of regenerating damaged heart muscle in primates, a US study has found...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Very small beta-thalassemia gene therapy trial gets investors' blood up

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856